Infimer (Israel) Buy Hold or Sell Recommendation
INFR Stock | ILA 54.90 1.10 1.96% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Infimer is 'Strong Sell'. Macroaxis provides Infimer buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Infimer positions. The advice algorithm takes into account all of Infimer's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Infimer's buy or sell advice are summarized below:
Real Value 46.87 | Hype Value 54.9 | Market Value 54.9 | Naive Value 32.88 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Infimer given historical horizon and risk tolerance towards Infimer. When Macroaxis issues a 'buy' or 'sell' recommendation for Infimer, the advice is generated through an automated system that utilizes algorithms and statistical models.
Infimer |
Execute Infimer Buy or Sell Advice
The Infimer recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Infimer. Macroaxis does not own or have any residual interests in Infimer or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Infimer's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Strong Sell
Market Performance | OK | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Infimer Trading Alerts and Improvement Suggestions
Infimer is way too risky over 90 days horizon | |
Infimer appears to be risky and price may revert if volatility continues | |
The company has accumulated 289 K in total debt. Infimer has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Infimer until it has trouble settling it off, either with new capital or with free cash flow. So, Infimer's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Infimer sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Infimer to invest in growth at high rates of return. When we think about Infimer's use of debt, we should always consider it together with cash and equity. | |
The entity reported the revenue of 378 K. Net Loss for the year was (7.99 M) with loss before overhead, payroll, taxes, and interest of (899 K). | |
Infimer has accumulated about 14 K in cash with (1.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
Roughly 14.0% of the company shares are held by company insiders |
Infimer Returns Distribution Density
The distribution of Infimer's historical returns is an attempt to chart the uncertainty of Infimer's future price movements. The chart of the probability distribution of Infimer daily returns describes the distribution of returns around its average expected value. We use Infimer price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Infimer returns is essential to provide solid investment advice for Infimer.
Mean Return | 8.32 | Value At Risk | -33.14 | Potential Upside | 29.44 | Standard Deviation | 5,490 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Infimer historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Infimer Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Infimer or Chemicals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Infimer's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Infimer stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 7.67 | |
β | Beta against NYSE Composite | 5.17 | |
σ | Overall volatility | 18.07 | |
Ir | Information ratio | 0.11 |
Infimer Volatility Alert
Infimer is showing large volatility of returns over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Infimer's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Infimer's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Infimer Fundamentals Vs Peers
Comparing Infimer's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Infimer's direct or indirect competition across all of the common fundamentals between Infimer and the related equities. This way, we can detect undervalued stocks with similar characteristics as Infimer or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Infimer's fundamental indicators could also be used in its relative valuation, which is a method of valuing Infimer by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Infimer to competition |
Fundamentals | Infimer | Peer Average |
Return On Asset | -0.33 | -0.14 |
Operating Margin | (9.80) % | (5.51) % |
Current Valuation | 25.15 M | 16.62 B |
Shares Outstanding | 1.06 M | 571.82 M |
Shares Owned By Insiders | 14.32 % | 10.09 % |
Shares Owned By Institutions | 10.35 % | 39.21 % |
Price To Earning | (867.76) X | 28.72 X |
Price To Sales | 4,759 X | 11.42 X |
Revenue | 378 K | 9.43 B |
Gross Profit | (899 K) | 27.38 B |
EBITDA | (3.15 M) | 3.9 B |
Net Income | (7.99 M) | 570.98 M |
Cash And Equivalents | 14 K | 2.7 B |
Cash Per Share | 0.01 X | 5.01 X |
Total Debt | 289 K | 5.32 B |
Current Ratio | 0.02 X | 2.16 X |
Book Value Per Share | (5.82) X | 1.93 K |
Cash Flow From Operations | (1.59 M) | 971.22 M |
Earnings Per Share | (5.30) X | 3.12 X |
Number Of Employees | 23.7 K | 18.84 K |
Beta | 1.52 | -0.15 |
Market Capitalization | 17.99 M | 19.03 B |
Z Score | 37.2 | 8.72 |
Last Dividend Paid | 589.96 |
Infimer Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Infimer . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Infimer Buy or Sell Advice
When is the right time to buy or sell Infimer? Buying financial instruments such as Infimer Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Infimer in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Wireless Thematic Idea Now
Wireless
Companies providing wireless technology and communication services. The Wireless theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Wireless Theme or any other thematic opportunities.
View All Next | Launch |
Check out Infimer Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Infimer Stock analysis
When running Infimer's price analysis, check to measure Infimer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infimer is operating at the current time. Most of Infimer's value examination focuses on studying past and present price action to predict the probability of Infimer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Infimer's price. Additionally, you may evaluate how the addition of Infimer to your portfolios can decrease your overall portfolio volatility.
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |